Litestream Ventures unveils plans for 'click-to-invest' TV series
Venture media firm Litestream Ventures is hoping the in-development TV series will challenge the likes of Dragons’ Den
Source: growthbusiness.co.uk
📰 Daniel Getts News
Daniel Getts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Getts. Real-time updates on events, politics, business and more.
Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes
/PRNewswire/ -- Prime Medicine, Inc. (Nasdaq: PRME) ("Prime Medicine") and Myeloid Therapeutics, Inc. ("Myeloid"), today announced resolution of all of their...
Source: prnewswire.com
After the Moderna COVID-19 vaccine, Flagship a new hit
The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow.
Source: fortune.com
Myeloid Therapeutics Raises $73M in Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Al Iskandariyah United Kingdom Daniel Getts Myeloid Therapeutics Hatteras Investment Partners Moore Strategic
Source: finsmes.com
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, announced today the completion of a $73 million financing...
Source: prnewswire.com
Myeloid Therapeutics Presents Late-Breaking Data on Multiple Platforms at the American Association for Cancer Research (AACR) 2023 Annual Meeting
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced its presentation of two posters at the...
United States United Kingdom Daniel Getts Amy Conrad American Association For Cancer Research Prnewswire Myeloid Therapeutics Inc
Source: prnewswire.com
Creating a genetic medicine manufacturing ecosystem: part 4
We are on the precipice of an explosion in local manufacturing of genetic medicines on a scale never seen before, with global equitable access.
Source: labonline.com.au
Myeloid Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that management will present at the...
Source: prnewswire.com
Myeloid Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that Daniel Getts, Ph.D., CEO of Myeloid,...
Source: prnewswire.com
Myeloid Therapeutics Strengthens Senior Team to Support the Expansion of its Manufacturing Capabilities
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company harnessing the power of myeloid and innate biology to...
United States United Kingdom France General Juniper Point University Of Massachusetts Eric Chapdelaine
Source: prnewswire.com